Two ophthalmologists share how Topcon’s Triton OCT makes a difference in their clinics.

EYLEA: The FDA approved VEGF inhibitor for ROP

Why we must strive for more precise visualization systems and treatment approaches when it comes to primary open-angle glaucoma

George Spaeth discusses his career, personal life, and the importance of listening to patients

Our image of the month, from the Ophthalmic Photographers Society

Non-invasive intracranial pressure technology to improve glaucoma diagnosis

A quick dip into the most interesting glaucoma research

Can myopia be reversed?

Two disease pathways identified in AMD

Here’s how amniotic membranes can help anterior segment surgeons